January 25, 2012 — Philips Healthcare announced the release of the Xper Flex Cardio Physiomonitoring system, a hemodynamic cardiac monitoring solution used to facilitate invasive investigation of heart and vascular disease.

January 23, 2012 – Boston Scientific Corp. said the U.S. District Court for the District of New Jersey has found all the asserted patents for a coronary stent in a lawsuit brought by Johnson & Johnson to be invalid and entered judgment in favor of Boston Scientific.


The next big advancement in cardiac imaging is likely to be computed tomography (CT) perfusion imaging. This enables one commonly available modality to image both the detailed anatomy and function of the heart at the same time. The impact on medicine could reduce healthcare costs by eliminating some hospital stays, cutting the number of tests and speeding patient diagnosis.

January 23, 2012 — CardioComm Solutions, Inc. a provider of ECG acquisition and management software solutions, received clearance from the U.S. Food and Drug Administration (FDA) for over-the-counter (OTC) sales and marketing of their consumer-based, hand-held heart rhythm monitor known as the HeartCheck Pen Handheld ECG.

January 23, 2012 — A collection of real-life data from 5,000 atrial fibrillation (AF) patients across seven countries will generate invaluable insights into one of Europe's leading causes of stroke. Daiichi Sankyo Europe GmbH today announced the enrolment of the first patient into the Prevention of thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF).

January 23, 2012 — Pregnant women who develop dangerous blood clots in the leg often forgo the most effective treatment for fear of harming the baby. Yet treatment to remove the clot is not only safe, it can prevent serious problems, including death, suggests research being presented at the 24th International Symposium on Endovascular Therapy (ISET).

January 20, 2012 - BridgePoint Medical Inc. this week signed an agreement with Covidien to exclusively license the rights to its peripheral vascular products used to treat chronic total occlusions (CTO).  The agreement includes the BigBoss and Mantaray catheters and the Mantaray guidewire. The terms of the agreement were not disclosed.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now